StonvexLoading…
StonvexStonvexStonvexCore line items from HHH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $235.92M | $1.47B | $850.44M | $460.21M |
Operating Income | $50.68M | $331.51M | $305.36M | $115.79M |
Net Income | $8.23M | $123.90M | $117.90M | $-1.61M |
EPS (Diluted) | $0.14 | $2.21 | $2.15 | $-0.03 |
Total Assets | $11.25B | $10.64B | $10.70B | $10.30B |
Total Liabilities | $7.40B | $6.80B | $6.86B | $6.59B |
Cash & Equivalents | $1.84B | $1.47B | $1.46B | $1.44B |
Free Cash Flow OCF − CapEx | $-244.24M | $417.61M | $69.02M | $-68.71M |
Shares Outstanding | 59.63M | 59.37M | 59.39M | 59.36M |